Dietary Supplementation with Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses in Elderly Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial

Influenza-like illness (ILI) remains a major cause of severe mortality and morbidity in the elderly. Aging is associated with a decreased ability to sense pathogens and mount effective innate and adaptive immune responses, thus mandating the development of protective nutraceuticals. Biobran/MGN-3, a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ahmed F. Elsaid, Sudhanshu Agrawal, Anshu Agrawal, Mamdooh Ghoneum
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	Biobran/MGN-3 old adults influenza-like illness NK cell activity RIG-1 MDA5 Nutrition. Foods and food supply TX341-641
Acceso en línea:	https://doaj.org/article/f5088a83e5d447798cce6bb45e21dc0a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f5088a83e5d447798cce6bb45e21dc0a
record_format	dspace
spelling	oai:doaj.org-article:f5088a83e5d447798cce6bb45e21dc0a2021-11-25T18:37:00ZDietary Supplementation with Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses in Elderly Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial10.3390/nu131141332072-6643https://doaj.org/article/f5088a83e5d447798cce6bb45e21dc0a2021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/4133https://doaj.org/toc/2072-6643Influenza-like illness (ILI) remains a major cause of severe mortality and morbidity in the elderly. Aging is associated with a decreased ability to sense pathogens and mount effective innate and adaptive immune responses, thus mandating the development of protective nutraceuticals. Biobran/MGN-3, an arabinoxylan from rice bran, has potent anti-aging and immunomodulatory effects, suggesting that it may be effective against ILI. The objective of the current study was to investigate the effect of Biobran/MGN-3 on ILI incidence, natural killer (NK) cell activity, and the expressions of RIG-1 (retinoic acid-inducible gene 1), MDA5 (melanoma differentiation-associated protein 5), and their downstream signaling genes ISG-15 (interferon-stimulated genes 15) and MX1 (myxovirus (influenza) resistance 1, interferon-inducible). A double-blind, placebo-controlled clinical trial included eighty healthy older adults over 55 years old, 40 males and 40 females, who received either a placebo or Biobran/MGN-3 (500 mg/day) for 3 months during known ILI seasonality (peak incidence) in Egypt. The incidence of ILI was confirmed clinically according to the WHO case definition criteria. Hematological, hepatic, and renal parameters were assessed in all subjects, while the activity of NK and NKT (natural killer T) cells was assessed in six randomly chosen subjects in each group by the degranulation assay. The effect of Biobran/MGN-3 on RIG-1 and MDA5, as well as downstream ISG15 and MX1, was assessed in BEAS-2B pulmonary epithelial cells using flow cytometry. The incidence rate and incidence density of ILI in the Biobran/MGN-3 group were 5.0% and 0.57 cases per 1000 person-days, respectively, compared to 22.5% and 2.95 cases per 1000 person-days in the placebo group. Furthermore, Biobran/MGN-3 ingestion significantly enhanced NK activity compared to the basal levels and to the placebo group. In addition, Biobran/MGN-3 significantly upregulated the expression levels of RIG-1, MDA5, ISG15, and MX1 in the human pulmonary epithelial BEAS-2B cell lines. No side effects were observed. Taken together, Biobran/MGN-3 supplementation enhanced the innate immune response of elderly subjects by upregulating the NK activity associated with reduction of ILI incidence. It also upregulated the intracellular RIG-1, MDA5, ISG15, and MX1 expression in pulmonary epithelial tissue cultures. Biobran/MGN-3 could be a novel agent with prophylactic effects against a wide spectrum of respiratory viral infections that warrants further investigation.Ahmed F. ElsaidSudhanshu AgrawalAnshu AgrawalMamdooh GhoneumMDPI AGarticleBiobran/MGN-3old adultsinfluenza-like illnessNK cell activityRIG-1MDA5Nutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 4133, p 4133 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Biobran/MGN-3 old adults influenza-like illness NK cell activity RIG-1 MDA5 Nutrition. Foods and food supply TX341-641
spellingShingle	Biobran/MGN-3 old adults influenza-like illness NK cell activity RIG-1 MDA5 Nutrition. Foods and food supply TX341-641 Ahmed F. Elsaid Sudhanshu Agrawal Anshu Agrawal Mamdooh Ghoneum Dietary Supplementation with Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses in Elderly Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial
description	Influenza-like illness (ILI) remains a major cause of severe mortality and morbidity in the elderly. Aging is associated with a decreased ability to sense pathogens and mount effective innate and adaptive immune responses, thus mandating the development of protective nutraceuticals. Biobran/MGN-3, an arabinoxylan from rice bran, has potent anti-aging and immunomodulatory effects, suggesting that it may be effective against ILI. The objective of the current study was to investigate the effect of Biobran/MGN-3 on ILI incidence, natural killer (NK) cell activity, and the expressions of RIG-1 (retinoic acid-inducible gene 1), MDA5 (melanoma differentiation-associated protein 5), and their downstream signaling genes ISG-15 (interferon-stimulated genes 15) and MX1 (myxovirus (influenza) resistance 1, interferon-inducible). A double-blind, placebo-controlled clinical trial included eighty healthy older adults over 55 years old, 40 males and 40 females, who received either a placebo or Biobran/MGN-3 (500 mg/day) for 3 months during known ILI seasonality (peak incidence) in Egypt. The incidence of ILI was confirmed clinically according to the WHO case definition criteria. Hematological, hepatic, and renal parameters were assessed in all subjects, while the activity of NK and NKT (natural killer T) cells was assessed in six randomly chosen subjects in each group by the degranulation assay. The effect of Biobran/MGN-3 on RIG-1 and MDA5, as well as downstream ISG15 and MX1, was assessed in BEAS-2B pulmonary epithelial cells using flow cytometry. The incidence rate and incidence density of ILI in the Biobran/MGN-3 group were 5.0% and 0.57 cases per 1000 person-days, respectively, compared to 22.5% and 2.95 cases per 1000 person-days in the placebo group. Furthermore, Biobran/MGN-3 ingestion significantly enhanced NK activity compared to the basal levels and to the placebo group. In addition, Biobran/MGN-3 significantly upregulated the expression levels of RIG-1, MDA5, ISG15, and MX1 in the human pulmonary epithelial BEAS-2B cell lines. No side effects were observed. Taken together, Biobran/MGN-3 supplementation enhanced the innate immune response of elderly subjects by upregulating the NK activity associated with reduction of ILI incidence. It also upregulated the intracellular RIG-1, MDA5, ISG15, and MX1 expression in pulmonary epithelial tissue cultures. Biobran/MGN-3 could be a novel agent with prophylactic effects against a wide spectrum of respiratory viral infections that warrants further investigation.
format	article
author	Ahmed F. Elsaid Sudhanshu Agrawal Anshu Agrawal Mamdooh Ghoneum
author_facet	Ahmed F. Elsaid Sudhanshu Agrawal Anshu Agrawal Mamdooh Ghoneum
author_sort	Ahmed F. Elsaid
title	Dietary Supplementation with Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses in Elderly Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial
title_short	Dietary Supplementation with Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses in Elderly Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial
title_full	Dietary Supplementation with Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses in Elderly Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial
title_fullStr	Dietary Supplementation with Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses in Elderly Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial
title_full_unstemmed	Dietary Supplementation with Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses in Elderly Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial
title_sort	dietary supplementation with biobran/mgn-3 increases innate resistance and reduces the incidence of influenza-like illnesses in elderly subjects: a randomized, double-blind, placebo-controlled pilot clinical trial
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/f5088a83e5d447798cce6bb45e21dc0a
work_keys_str_mv	AT ahmedfelsaid dietarysupplementationwithbiobranmgn3increasesinnateresistanceandreducestheincidenceofinfluenzalikeillnessesinelderlysubjectsarandomizeddoubleblindplacebocontrolledpilotclinicaltrial AT sudhanshuagrawal dietarysupplementationwithbiobranmgn3increasesinnateresistanceandreducestheincidenceofinfluenzalikeillnessesinelderlysubjectsarandomizeddoubleblindplacebocontrolledpilotclinicaltrial AT anshuagrawal dietarysupplementationwithbiobranmgn3increasesinnateresistanceandreducestheincidenceofinfluenzalikeillnessesinelderlysubjectsarandomizeddoubleblindplacebocontrolledpilotclinicaltrial AT mamdoohghoneum dietarysupplementationwithbiobranmgn3increasesinnateresistanceandreducestheincidenceofinfluenzalikeillnessesinelderlysubjectsarandomizeddoubleblindplacebocontrolledpilotclinicaltrial
_version_	1718410929224286208

Dietary Supplementation with Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses in Elderly Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial

Ejemplares similares